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Identifying Factors Underlying the Decision for Genetic Carrier Screening Among
Women in Montgomery County
Scholarly Project Final Report
Sowon Kim
Rose Maxwell, Assistant Professor, Obstetrics & Gynecology
Literature Review
As medical scientific technologies evolve, numerous medical tests help not only
physicians with their clinical judgment, but also patients by empowering them with more
knowledge of their own health. An example is Genetic Carrier Screening (GCS) [1-2].
Genetic Carrier Screening (GCS) is a genetic test that allows patients to find out if
they carry genes for certain genetic disorders. The results of the test enable patients to
make changes to their family planning decisions and prenatal care when appropriate and
allow them the opportunity to seek further medical and social support [3]. The clinical
utility of GCS is evident in the significant decrease in the number of Tay-Sachs disease
incidences between 1970 and 2000 (a 90% decrease) and decreases in the number of
newborns born with cystic fibrosis and thalassemia since the development of GCS in
1970s [4-7].
Despite these health benefits and notable clinical utility of GCS, GCS has not
been utilized in most nations due to moral and ethical controversy among the public [812]. Certain populations have shown to have positive attitudes toward GCS, such as those
who have a higher risk of having severe recessive disorders. African Americans, for
example, are supportive of sickle cell carrier screening [13-15]. Also, the majority of
cystic fibrosis patients and their family members support the practice of GCS [16-19].
However, others fear that GCS might result in unnecessary feelings of guilt and a greater
burden to parents [17].

Other factors have been shown to be associated with attitudes and intentions
towards GCS, even within at risk populations. One study demonstrated that among
African American patients, their socio-demographic factors (age, education), previous
screening knowledge, and the presence of perceived threat were associated with the
patient’s intention to undergo GCS for sickle cell trait screening [20]. In cystic fibrosis
patients, other studies have shown that socioeconomic status, ethnicity and sex affected
patients’ decisions to accept GCS [21-27].
There are limited studies that address factors that affect the decision-making
process of the general public for GCS. One study examined the impression and attitudes
about preconception GCS among 468 OB-GYN female patients in Montgomery County,
OH. The study showed that although patients believed that it would be beneficial to know
their carrier status and that it is their responsibility to undergo testing, they did not want
to go through GCS [28]. That study did not investigate the socioeconomic and
demographic factors that may have impacted the decision to choose GCS among this
population. Therefore, the objective of this study is to describe socioeconomic and
demographic factors affecting these female patients’ desire to undergo GCS.
Hypothesis/Specific Aims/Research Questions
This paper explores the socioeconomic and demographic factor differences
between patients who desire to undergo GCS and patients who do not desire to undergo
GCS, and their respective correlations.
Socioeconomic factors that will be examined in this study are types of medical
insurance and highest level of education. Demographic factors include age and religious
affiliation.
I hypothesize that patients with higher education (some college and beyond) and
private insurance are more willing to undergo GCS. In regards to the demographic
factors, I hypothesize that older patients are more willing to go through GCS and that
patients with religious beliefs are less likely to undergo GCS.
Methodology

Context
This is a secondary data analysis of the data collected in the study that examined
attitudes of 468 OB-GYN female patients in Montgomery County, OH toward GCS [28].
Data for the OB-GYN patients in Montgomery County study was collected via an
anonymous survey distributed to 468 patients attending OB/GYN visits at Wright State
Physicians and at Five Rivers Center for Women’s Health from July 2015 to August
2016. Survey respondents included patients who are currently pregnant, and those
considering future fertility or currently undergoing fertility treatment. Participants were
over 18 years old and able to understand and write in English. All responses were
collected via convenience sampling of a self-administered survey containing a front page
with consent information. The final sample for analysis was 468 women.
Data Collection
A descriptive self-administered survey composed of 31 questions was distributed
to the subjects, who completed and returned the survey at the physician’s office. The
questionnaire was designed to gauge participants’ attitudes and perspectives regarding
GCS with both closed and open-ended questions. The survey questions include patient
demographics (age, gender, ethnicity and religious preferences), socioeconomics (highest
level of education and type of health insurance), and questions to measure patient
opinions on GCS (positive or negative attitudes towards GCS, desire to undergo GCS,
and how much a patient would be willing to pay to have GCS, etc.) For my study, I will
focus on associations between patients’ age, religious affiliation, highest level of
education, type of health insurance, and their desire to go through GCS.
The independent variables of interest include socioeconomic factors such
as highest level of education and type of health insurance and demographic factors such
as patients’ age and religious affiliation. Patients’ education levels were subdivided into
the following three categories: high school/GED, some college, and graduate
school/doctorate level. They were also classified on the basis of religious affiliation.

Religious affiliation was classified into Christian, Judaism, Islam, Buddhism,
Hinduism, Jehovah’s Witness, no religious affiliation and other. For the purpose of this
study, I will simply classify religion as “religiously affiliated” and “no religious
affiliation.” Type of health insurance that the individuals have were recorded as
“Private,” “Medicaid,” and “Self-pay/none.” Participants’ age was measured as a
continuous variable in which they simply answered with a number. However, I will
divide the variable into three age groups, namely, 18-28, 29-36, and 37+ .

The dependent variable is individuals’ desire to go through GCS. Participants

were asked to answer the question, “Do you desire to undergo Genetic Carrier
Screening?” with “Yes” and “No” as answer choices.
No power analysis was done because my study is a secondary data analysis.
Therefore, the available data set is predetermined.
Data Analysis
This is a retrospective quantitative analysis of existing survey data.
Socioeconomic and demographic factors that I analyze are different types of categorical
data; nominal categorical data: religious affiliation and type of health insurance; ordinal
categorical data: highest level of education; continuous data: age.
Considering categorical independent and dependent outcomes and the purpose of
the study, which is looking for correlations between the two, I am going to utilize ChiSquare testing to analyze the data. Statistical analysis will be conducted using IBM
version 24.0 Statistical Package for the Social Sciences software (SPSS) with a p-value of
0.05.
Data cleaning was previously completed to confirm that there were no data entry
errors. To prevent any risk of bias, missing data will be excluded from the analysis.
Therefore, the sample size might fluctuate due to the lack of response.

Results

Demographics
Four hundred sixty-eight patients participated in the survey. This study focused on
female patients only. Table 1 presents the demographics of the survey respondents. These
participants were categorized into three groups: 64.1% (n=300) undergoing general
gynecologic care, 22.4% (n=105) currently pregnant, and 13.5% (n=63) considering or
receiving fertility treatments. The mean age was 30.03 ± 6.98 years with a range of 1863. The three groups were similar in age (see Table 1). The majority of women were
Caucasian (77.4%; see Table 1).

Table 1 Patient demographics and distribution (N=468)
Demographic

Proportion/Mean

Patient type [%(n)]
General gynecology

64.1% (300)

Currently pregnant

22.4% (105)

Considering or receiving fertility treatment

13.5% (63)

Average Age for Patient Type (mean ± SD)
General gynecology

30.21±7.65

Currently pregnant

28.51±5.05

Considering or receiving fertility treatment

31.67±5.89

Gender
Female

100% (468)

Ethnicity
Caucasian

77.4% (362)

African American

16.2% (76)

Caucasian-African American

0.6% (3)

Asian-Hispanic

1.3% (6)

Pacific Islander

0.2% (1)

Other

4.3% (20)

Patients’ desire to undergo GCS based on socioeconomic and demographic factors
A greater number of patients in every age group did not desire to have GCS,
compared to patients who did desire to have GCS. Of those in the 18-28 age group,
43.6% (n=65) desired to undergo GCS while 56.4% (n=84) did not. For the 29-36 age
group, 36.8% (n=57) desired to undergo GCS while 63.2% (n=98) did not. Among those
whose age is greater than or equal to 37, even a greater proportion of patients 73.0%
(n=46) did not wish to have GCS while only 27.0% (n=17) wished to have GCS. No
significant relationship between patients’ age and their willingness to go through GCS
was found (P=ns) (See Table 2).
Similarly, a greater number of patients responded that they would not like to
undergo GCS, compared to the number of patients who did desire GCS, no matter what
their insurance type was. Among those with private insurance, 36.2% (n=100) wished to
go through GCS while 63.8% (n=176) did not. Of those with Medicaid 41.4% (n=36)
desired GCS while 58.6% (n=51) did not. Self-pay patients were split in half in terms of
their desire to go through GCS. Again, there was no significant relationship between
respondents’ type of insurance and their desire to undergo GCS (P=ns) (See Table 2).
Participants’ highest level of education did not affect their desire to have GCS
(P=ns). Of those whose highest level of education was high school or GED, 38.6%
(n=27) desired to undergo GCS while 61.4% (n=43) did not. Among participants whose
highest level of education was some college, 36.6% (n=59) desired to go through the test
while 63.4% (n=102) did not. Lastly, of patients whose highest level of education was
graduate school or doctorate level, 40.0% (n=42) wished to go through GCS while the
rest, 60.0% (n=63) did not wish to undergo GCS (See Table 2).
Participants’ religious affiliation had a significant relationship with their desire to
undergo GCS (P<0.05). Of those who are not religiously affiliated, 45.3% (n=53)
answered that they desired the test while 54.7% (n=64) replied that they did not.
However, among those who are religiously affiliated, 34.1% (n=86) desired to have the
test while a significantly greater number of patients 65.9% (n=166) did not (See Table 2).
Religiously affiliated patients were more likely to refuse GCS.

Table 2 Patients’ desire to undergo GCS based on age, type of insurance, education level,
and religious affiliation
Desire to Undergo GCS

P

Yes

No

<0.07

18-28

43.6% (65)

56.4% (84)

29-36

36.8% (57)

63.2% (98)

37+

27.0% (17)

73.0% (46)

Private

36.2% (100)

63.8% (176)

Medicaid

41.4% (36)

58.6% (51)

Self Pay/None

50.0% (3)

50.0% (3)

Age [%(n)]

Type of Insurance [%(n)]

<0.575

Education [%(n)]

<0.86

High School/GED

38.6% (27)

61.4% (43)

Some College

36.6% (59)

63.4% (102)

Graduate School/Doctorate Level

40.0% (42)

60.0% (63)

Religiously Affiliated [%(n)]

<0.04

No

45.3% (53)

54.7% (64)

Yes

34.1% (86)

65.9% (166)

Patients’ desire to undergo GCS based on previous pregnancy history
Following analysis of the relationship between socioeconomic and demographic
factors and desire to undergo GCS, previous pregnancy history was identified as another
potential factor affecting patients’ desire to undertake GCS. Hence, a closer look at the
relationship between participants’ previous pregnancy history and their willingness to go
through GCS was performed. Those who desired to undergo GCS had a lower number of
pregnancies and number of living children than those who did not desire to undergo GCS,
but the groups were similar for number of miscarriages and elective abortions (see Table
3).

In addition, those who had a previous abnormal ultrasound or abnormal prenatal
testing were not more likely to report that they desired to undergo GCS (see Table 4).
Table 3 Descriptive statistics of participants’ pregnancy history

Number of Pregnancies
Number of Miscarriages
Number of Elective Abortion
Number of Living Children

Desire

N

Mean

Std. Deviation

P

Yes

140

1.24

1.644

<0.001

No

237

1.84

1.775

Yes

139

0.36

0.780

No

234

0.38

1.099

Yes

136

0.12

0.405

No

231

0.12

0.437

Yes

138

0.64

1.139

No

235

1.11

1.160

<0.82
<0.99
<0.001

Table 4 Patients’ desire to undergo GCS based on history of abnormal ultrasound and
prenatal screening in a previous pregnancy
Desire to Undergo GCS

P

Yes

No

<0.10

Yes

41.2% (7)

58.8% (10)

No

37.7% (126)

62.3% (208)

Abnormal Ultrasound [%(n)]

Abnormal Prenatal Screening [%(n)]

<0.35

Yes

53.8% (7)

46.2% (6)

No

37.6% (126)

62.4% (209)

Participants’ attitudes toward GCS
The majority of patients reported a positive or neutral attitude toward GCS; only
nine patients had negative attitude toward GCS (See Table 5). However, interestingly, a

larger number of participants did not wish to have GCS for every sub-group that was
examined.
Table 5 Participant’s attitudes toward GCS (N=466)
Attitudes toward GCS [%(n)]
Positive

Negative

Neutral

Unsure

45.9% (214)

1.9% (9)

47.6% (222)

4.5% (21)

Currently pregnant patients’ desire to undergo GCS
We further explored the subgroup of “Currently pregnant” patients’ responses to
determine whether “currently pregnant” patients might have a greater interest in learning
about their fetus’ health and potential genetic disorders. “Currently pregnant” patients’
age, type of insurance, and religious affiliation did not have a significant association with
their desire to go through GCS (see Table 6). H highest level of education was
significantly related to their wish to undergo GCS with women having a higher level of
education being less likely to desire GCS (p<0.05).
Table 6 Desire to undergo GCS based on age, type of insurance, education level, and
religious affiliation (N=82) among women who were currently pregnant
Desire to Undergo GCS

P

Yes

No

<0.66

18-28

28.1% (9)

71.9% (23)

29-36

23.4% (11)

76.6% (36)

37+

50.0% (1)

50.0% (4)

Private

21.7% (13)

78.3% (47)

Medicaid

38.1% (8)

61.9% (13)

Self Pay/None

0.0% (0)

100.0% (1)

Age [%(n)]

Type of Insurance [%(n)]

<0.28

Education [%(n)]

<0.05

High School/GED

46.7% (7)

53.3% (8)

Some College

12.9% (4)

87.1% (27)

Graduate School/Doctorate Level

27.6% (8)

72.4% (21)

Religiously Affiliated [%(n)]

<0.77

No

27.6% (8)

72.4% (21)

Yes

24.5% (13)

75.5% (40)

Discussion
We found there was no difference in the desire to undergo GCS related to age,
type of insurance, or highest level of education. However, when only currently pregnant
women were examined, those with at least some college were less likely to desire to
undergo GCS than women with high school as their highest level of education. Previous
studies have shown that patients with higher education tend to worry more about the
possibility of eugenics and the use of new biotechnology in medicine than others [29-30].
However, numerous studies have shown that high socioeconomic status with higher
educational level and income are associated with a greater acceptance of GCS [31-36].
Additionally, studies show that women with higher education are more favorable toward
abortion compared to other women when they are at risk of sacrificing their career [37].
This study shows that women who reported having a religious affiliation were less likely
to desire GCS than women reporting no religious affiliation. Previous studies support that
religiously affiliated patients, no matter of their affiliated religion or ethnicity, do not
consider terminating the pregnancy as an option in case of an affected child because of
their faith [28-40]. This is not surprising because religions have a quite consolidated view
on preserving and protecting life. And patients with religious beliefs are more likely to
have a bigger support system that can certainly help them emotionally and spiritually [4143].
Another study shows that even though a majority of Lutheran pastors believe that
genetic counseling is beneficial and like to be involved in the decision-making process of
family planning, they do not regard abortion as an option for the fetus with Huntington
disease and Down syndrome [44]. However, many of the patients agree that termination

may be allowed in case of legal issues such as rapes are involved or when the mother’s
life is in danger [38].
The positive correlation between educational attainment and religious services
attendance might explain the unwillingness of patients with a higher education and
religious belief to go through GCS [45]. Also, patients with higher level of education are
more likely to have more means to raise children with special needs.
Women with fewer pregnancies and fewer living children are more likely to
desire GCS. There have been studies that found the same: patients with fewer or no
children are more likely to undertake GCS out of uncertainty and worry about their
pregnancy [34,46]. Having previous abnormal ultrasound or prenatal testing did not
change their desire to have GCS compared to those without this history. There is no study
to explain this finding, and this undermines the idea of the perceived threat that will be
discussed later.
The majority of women reported a positive or neutral attitude toward GCS,
however, their desire to undertake GCS was low.
This inconsistency between patients’ attitudes and behavior toward GCS seems to
be common among patients. [8,12, 47-49]. It can be possibly explained by patients’
perceived threat. The perceived threat is a measure of how much risk an individual
believes that he or she might have a trait for genetic diseases. If a patient has direct or
distant family members with genetically transmitted health conditions, his or her
perceived threat is likely to be higher compared to others with no family history of
inheritable illnesses. How much they know about the severities and consequences of
those diseases might affect their perceived threat as well. Patients with a greater
perceived threat are more likely to agree to have GCS for both inheritable and other
nonheritable disorders [20,28]. On the other hand, patients with low perceived threat
would be less willing to have GCS even if they do not necessarily have negative opinions
regarding GCS.
Participants’ perceived norm might be another explanation for the discrepancy
observed between their attitudes and behavior [28,50-52]. Perceived norm is the
perceived social pressure to perform or not to perform certain behaviors [52].
Respondents are likely to be aware of the controversy over GCS due to ethical and moral

responsibilities. Just being aware of this negative connotation and impression about GCS
is likely to affect patients’ decision when it comes to undergoing GCS. Even though
patients might not have negative opinions on GCS, they might be concerned of being
judged by their family members, friends, or even general public to undergo GCS.
Lastly, respondents’ fear that GCS might result in unnecessary feelings of guilt
and a greater amount of burden to them as parents might prevent them from taking GCS
[17]. Patients and their partners, who do not wish to live with the distress sprung from the
knowledge of their carrier status, support the “right to not know.” They believe that if
nothing can be altered about their carrier status, knowing their carrier status would result
in a tremendous amount of anxiety and stress with no solution to it [48-49].
Limitations
The study has several limitations. This was a secondary analysis of existing data
with a questionnaire developed previously for another study. The questionnaire does not
include ways to measure content validity or internal consistency. However, the question
that measures participant’s desire to go through GCS was clearly worded as “Do you
desire to undergo Genetic Carrier Screening?” with “Yes” and “No.” Therefore, it meets
face validity.
The data were collected via self-report of a convenience sample, and most
participants identified themselves as Caucasian females with Christian faith living in
Ohio. Therefore, the data might include respondent bias and be difficult to apply to the
general population. This study was a cross-sectional study in which analysis of causation
or changes over an extended length of time would not be applicable. Lastly, employment
status or income of participant could have assessed their socioeconomic status but were
not included in this study.
We examined patients’ pregnancy history and its relationship with willingness to
undergo GCS. In addition, there could be different variables (i.e. ethnicity, cultural
norms) that this study did not examine but may influence participants’ desire to have
GCS. Investigating these other confounding variables would be the next step in further

exploring the utility of GCS. Exploring association of respondents’ perceived threat and
norm and their decision regarding GCS will be able to provide further and deeper
understanding of this study’s results.
Conclusion
Awareness of the association between religious belief and desire to undergo GCS
can help physicians prepare for conversations with patients about GCS. While education
level was not associated with the desire to undergo GCS in the overall group of patients,
women who were currently pregnant were less likely to desire GCS with increasing
levels of education. Few patients had a negative attitude toward GCS, although attitudes
toward GCS were not related to reported desire to undergo GCS. Future research may
include examination of the relationship of other factors, such as medical history,
pregnancy history, and cultural norms, and GCS. Understanding the influence of other
factors on the desire for GCS is important not only to reconcile the gap between benefits
and patient use of GCS but also to build stronger patient-physician rapport.

Appendix A Patient Survey
THIS SURVEY ASKS QUESTIONS THAT MAY BE SENSITIVE IN NATURE. THESE QUESTIONS
ARE THEORETICAL, AND ITS INTENTION IS NOT TO OFFEND OR IMPLY THAT GENETIC
CARRIER SCREENING WILL BE USED IN THIS WAY.
WE ARE INTERESTED IN SEEKING YOUR OPINION ABOUT THE POTENTIAL WAYS THAT THIS
TYPE OF SCREENING COULD BE USED IN THE FUTURE. YOU CAN RESPOND TO AS FEW, OR
AS MANY QUESTIONS AS YOU WOULD LIKE TO.
BY COMPLETING THE SURVEY, YOU ARE CONSENTING TO PARTICIPATION IN THIS
RESEARCH. WE WILL NOT HAVE ANY WAY OF IDENTIFYING YOU BASED ON THE ANSWERS
YOU GIVE TO THE SURVEY. THE DATA COLLECTED FROM THIS RESEARCH WILL NOT BE
USED TO IMPLEMENT POLICY THAT WILL ALTER INSURANCE COVERAGE. IF YOU HAVE
ANY QUESTIONS REGARDING THE SURVEY, PLEASE TEAR OFF THE BACK PAGE WHERE
YOU WILL FIND CONTACT INFORMATION FOR THE INVESTIGATORS CONDUCTING THIS
RESEARCH.

Please answer all questions to the best of your ability.
NOTE: definitions are provided for medical terms. All defined terms are bolded.
The end of the survey has all definitions listed in alphabetical order.
Full Disclosure: There are some sensitive topics covered in this study including
abortion. The Researchers conducting this study do not support any specific
viewpoints (positive or negative) regarding this or other sensitive topics.

1. Age: ______
2. Gender: Female Male
3. Ethnic group: Caucasian African American Asian Hispanic Pacific Islander Other:
______________

4. Education: High School GED Some College Graduate school Doctoral degree
Other: _______________
5. Geographic location:
Please specify State: __________________
6. Type of medical insurance: Private Medicaid Self Pay/none
7. Religious preference: Catholicism Protestantism Judaism Islam Buddhism Hinduism
No religious affiliation Other: _______________
8. Please provide numbers for your pregnancy history.
number of pregnancies: ___________ (regardless of outcome, and include current)
number of miscarriages? ____________
number of elective abortions? ________
number of living children: ___________
9.Are you currently pregnant? Yes No
10. Do you currently use contraception?
Yes No If yes, what type?_______________
11.Please select the category that most closely defines your current reproductive status.

 Sexually active with no intention of having a child in the near future
 Sexually active, willfully not using contraception, but uncertain about wanting to have a child in the
near future or wishing to leave it to chance

 Sexually active, with a partner whom I know I cannot produce a child with. For example, you are both
the same sex or one or both of you cannot have children.

Sexually active with the intention of having a child in the near future
12. Were you aware of Genetic Carrier Screening prior to your appointment today?
 Yes No Unsure why?:_______________________
13.If you answered yes to #12, please select the source from which you received this information.
 commercial media (TV, computer, billboards, etc.)
 OB/GYN
 genetics counselor

 fertility doctor
 other, please specify_______________________
14. Did you understand the material provided to you prior to this survey?
 Yes No Unsure why?: _____________________________
15. After reading the material, do you desire to undergo Genetic Carrier Screening?
 Yes No Unsure why?:_____________________________
16. If you are a genetic carrier for a disease, what would you choose to do next? Please select one option.
 Would have my partner screened
 Nothing, would not change plans
 Would choose to undergo In Vitro Fertilization (IVF)
 Would only choose prenatal screening in pregnancy

 Other (Please specify): _______________
17. Have you had a history of any of the following? Please answer Yes/No.
More than 2 miscarriages
 Yes No Unsure why?: _____________________________
Child with a genetic disease/disorder?
 Yes (if yes, please specify what disease/disorder)____________
 No Unsure why?: _____________________________
Abnormal ultrasound in a previous pregnancy?
 Yes No Unsure why?: _____________________________
Abnormal Prenatal Screening (Quad screen, First Trimester screen, Non invasive prenatal screening) in a
previous pregnancy?
 Yes No Unsure why?: _____________________________
Amniocentesis or Chorionic Villi Sampling (CVS) in a previous pregnancy?
 Yes No Unsure why?: _____________________________

18. Generally, how do you feel about genetic carrier screening?
 Positive
 Negative

 Neutral
 Unsure why?: _____________________________
19. Which of the following providers do you feel could adequately counsel you on the risks and benefits of
genetic carrier screening and explain the results of the test? Please select all that apply.
 Primary OB doctor
 High risk OB doctor
 Reproductive Endocrinologist doctor
 Family Practice doctor
 Genetics counselor
 Nurse midwife
 Nurse Practitioner
 I am not interested in being counseled by anyone
 Other (Please Specify): ___________________________
20. Considering your medical history and family history, do you feel genetic carrier screening should be
performed before any other testing?
 Yes No Unsure,
If yes, please explain why.: _____________________________
21. Do you feel that genetic carrier screening should be available to all fertility patients, defined as
women undergoing treatment with assisted reproductive technologies?
 Yes No Unsure why?: _____________________________
22. Do you feel that insurance should cover genetic carrier screening to women undergoing treatment
with assisted reproductive technologies?
 Yes No Unsure why?: _____________________________
23. Do you feel that genetic carrier screening should be offered to all pregnant women?
 Yes No Unsure why?: _____________________________
24. Do you feel that genetic carrier screening should be offered to all women of reproductive age
regardless of whether they are actively trying to conceive?
 Yes No Unsure why?: _____________________________
25. Which potential traits would you be interested in testing for by genetic carrier screening if they
became available? Please check all that apply.

 Inheritable disease (for example, cystic fibrosis or sickle cell)
 Autism
 Complex disease, such as diabetes or lupus
 Psychiatric conditions, such as depression or schizophrenia
 Adult-onset inheritable disease, such as breast or colon cancer
 Personality disorders, such as obsessive-compulsive disorder or oppositional defiant disorder
 I would not be interested in any of these options
26. Do you feel that doctors have a moral obligation to support limits on the genetic carrier screening that
is available to you?
 Yes No Unsure
Please explain your answer.
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
_________________________
27. Considering cost, when would you do genetic carrier screening? Check all that apply.

 if your insurance covered the testing?
 if insurance required a copay
 if insurance did not cover the testing

28. How much would you be willing to pay for genetic carrier screening as insurance does not currently
cover the test?
 I would not pay out of pocket
 $50-100
 $150-250
 $300-500
 $>500
29. What would lead you to have an abortion? Please check all that apply.
 I would NEVER get an elective abortion
 Diagnosed with fetal condition where survival is unlikely
 Diagnosed with severe fetal anomalies but survival is likely with severe disability
 Diagnosed with minor fetal anomalies and survival is likely with minor disability

 Unsure what I would do
 Other (please
explain);____________________________________________________________________
30.Please select which of the following statements more closely describes how you feel.

 I feel that finding out the results of a genetic test that could reveal I have a chance of passing on a
disease to a child such as cancer, heart disease, diabetes, other major illnesses or genetic diseases would
cause me to worry excessively and be a greater burden than not knowing.

I feel that it would be more beneficial to know the chance I have to pass on an illness to a child so I can
try to prevent future children from having disease.
31.Please select which of the following statements more closely describes how you feel
A potential mother has a responsibility to do everything in her power to make certain her child does not
suffer; this includes any genetic testing available to screen for potential illness.
 Regardless of the potential outcome for the offspring, the ability for the mother to choose to have
genetic testing or not is more important. Without this ability, the mother is viewed as less important than
the potential child she will have.

Definitions
Abortion: The act of choosing to end a pregnancy, during the first 28 weeks.
Amniocentesis: A test your OB/GYN does between 14-16 weeks of pregnancy to detect an abnormal baby,
such as one with Down Syndrome.
Chorionic Villi Sampling (CVS): A test your OB/GYN does between weeks 10-12 of pregnancy to detect
an abnormal baby, such as one with Down Syndrome.
Copay: A payment agreement where the patient pays a certain amount and the insurance company pays the
rest of the amount.
Genetic carrier: Someone who has a risk of passing a genetic abnormality to their children as determined
by testing.
Genetic Carrier Screening: A test you can have before becoming pregnant to determine your chances of
having an abnormal baby due to a genetic problem.
In Vitro Fertilization (IVF): A procedure that involves a fertility doctor who can harvest your eggs,
fertilize them with sperm outside of your body, then put one or more of them back into your body to help
you have a child.

Miscarriage: This occurs when a baby dies early in pregnancy (before the 20th week).
Prenatal Screening: Testing done once you are already pregnant to determine if the baby has any specific
abnormalities including Down Syndrome.
Ultrasound: A medical instrument that the OB/GYN places on your tummy to look at your developing
baby.
Quad Screen: A test your OB/GYN does between weeks 15-20 of pregnancy that can detect an abnormal
baby, such as one with Down Syndrome or with an abnormal spine.

References
1. Edwards JG, Feldman G, Goldberg J, et al. Expanded carrier screening in reproductive
medicine—points to consider. Obstet Gynecol. 2015; 125:653–62.
2. Dinh, AT, Rosner, BI, Atwood JC, et al. Health Benefits and Cost-Effectiveness of
Primary Genetic Screening for Lynch Syndrome in the General Population. Cancer Prev
Res(Philla). 2011;4(1):9–22.
3. Johansen Taber K., Beauchamp KA, Lazarin GA, et al. Clinical utility of expanded
carrier screening: results-guided actionability and outcomes. Genet Med.
2019;21(5):1041–8.
4. Kaback MM. Population-based genetic screening for reproductive counseling: the TaySachs disease model. Eur J Pediatr. 2000;159 Suppl 3:S192–5.
5. Castellani C, Picci L, Tridello G, et al. Cystic fibrosis carrier screening effects on birth
prevalence and newborn screening. Genet Med. 2016;18:145–51.
6. Bozkurt G. Results from the North Cyprus Thalassemia Prevention Program.
Hemoglobin. 2007;31:257–64.
7. Hale JE, Parad RB, Comeau AM. Newborn screening showing decreasing incidence of
cystic fibrosis. N Engl J Med. 2008;358:973–4.
8. Ekstrand Ragnar M, Tydén T, Kihlbom U, et al. Swedish parents’ interest in
preconception genetic carrier screening. Ups J Med Sci. 2016:121(4):289–94
9. Borry P, Henneman L, Lakeman P, et al. Preconceptional genetic carrier testing and
the com- mercial offer directly-to-consumers. Hum Reprod. 2011;26(5): 972–7.
10. Holtkamp KCA, Mathijssen IB, Lakeman P, et al. Factors for successful
implementation of population-based expanded carrier screening: learning from existing
initiatives. Eur J Pub Health. 2017;27(2):372–7.
11. De Wert GM, Dondorp WJ, Knoppers BM. Preconception care and genetic risk:
ethical issues. J Community Genet. 2012;3(3):221–8.
12. Schneider JL, Goddard KA, Davis J, et al. “Is it worth knowing?” focus group
participants’ perceived utility of genomic preconception carrier screening. J Genet Couns.
2016;25(1):135–45.

13. Acharya K, Lang CW, Ross LF. A pilot study to explore knowledge, attitudes, and
beliefs about sickle cell trait and disease. J Natl Med Assoc. 2009;101(11):1163–72.
14. Goldsmith JC, Bonham VL, Joiner CH, et al. Framing the research agenda for sickle
cell trait: building on the current understanding of clinical events and their potential
implications. Am J Hematol. 2012;87(3):340–6.
15. Long KA, Thomas SB, Grubs RE, et al. Attitudes and beliefs of African-Americans
toward genetics, genetic testing, and sickle cell disease education and awareness. J Genet
Couns. 2011;20(6):572–92.
16. Henneman L, Borry P, Chokoshvili D. Responsible decision of expanded carrier
screening. Eur J Hum Genet. 2016;24(6):1–12.
17. Conway SP, Allenby K, Pond MN. Patient and parental attitudes toward genetic
screening and its implications at an adult cystic fibrosis centre. Clin Genet. 1994;45(6):
308–12.
18. Janssens S, Chokoshvilli D, Binst C, et al. Attitudes of cystic fibrosis patients and
parents toward carrier screening and related reproductive issues. Eur J Hum Genet. 2016;
24(4):506–12.
19. Maxwell SJ, Kyne G, Molster C, et al. Perceptions of

population cystic fibrosis

prenatal and preconception carrier screening among individuals with cystic fibrosis and
their family members. Genet Test Mol Biomarkers. 2011;15(3):159–64.
20. Mayo-Gamble TL, Middlestadt SE, Lin HC, et al. Identifying Factors Underlying
the Decision for Sickle Cell Carrier Screening Among African Americans Within
Middle Reproductive Age. J Genet Couns. 2018;27(5):1302–11.
21. Chen L, Goodson P. Factors affecting decisions to accept or decline cystic fibrosis
carrier testing/screening: A theory-guided systematic review. Genet in Med. 2007;9(7):
442–50.
22. Sorenson JR, Cheuvront B, DeVellis B, et al. Acceptance of home and clinic-based
cystic fibrosis carrier education and testing by first, second, and third degree relatives of
cystic fibrosis patients. Am J Med Genet. 1997;70(2):121–9.
23. Honnor M, Zubrick SR, Walpole I, et al. Population screening for cystic fibrosis in
Western Australia: community response. Am J Med Genet. 2000;93(3):198–204.

24. Witt DR, Schaefer C, Hallam P, et al. Cystic fibrosis heterozygote screening in 5,161
pregnant women. Am J Hum Genet. 1996;58:823–835.
25. Clayton EW, Hannig VL, Pfotenhauer JP, Parker RA, et al. Lack of interest by nonpregnant couples in population-based cystic fibrosis carrier screening. Am J Hum Genet.
1996;58(4):617–27.
26. Loader S, Caldwell P, Kozyra A, et al. Cystic fibrosis carrier population screening in
the primary care setting. Am J Hum Genet. 1996;59(1):234–47.
27. Lafayette D, Abuelo D, Passero M, et al. Attitudes toward cystic fibrosis carrier and
prenatal testing and utilization of carrier testing among relatives of individuals with cystic
fibrosis. J Genet Couns. 1999;8(1):17–36.
28. Pereira N, Wood M, Luong E, et al. Expanded genetic carrier screening in clinical
practice: a current survey of patient impressions and attitudes. J Assist Reprod Genet.
2019;36(4):709–16.
29. Aro AR, Hakonen A, Hietala M, et al. Acceptance of genetic testing in a general
population: age, education and gender differences. Patient Educ Couns. 1997;322(1):419.
30. Macer DR. Perception of risks and benefits of in vitro fertilization, genetic
engineering and biotechnology. Soc Sci Med. 1994;38(1):23-33.
31. Sorenson JR, Cheuvront B, DeVellis B, et al. Acceptance of home and clinic-based
cystic fibrosis carrier education and testing by first, second, and third degree relatives of
cystic fibrosis patients. Am J Med Genet. 1997;70:121–9.
32. Honnor M, Zubrick SR, Walpole I, et al. Population screening for cystic fibrosis in
Western Australia: community response. Am J Med Genet. 2000;93:198–204.
33. Fang CY, Dunkel-Schetter C, Tatsugawa ZH, et al. Attitudes toward genetic carrier
screening for cystic fibrosis among pregnant women: the role of health beliefs and
avoidant coping style. Womens Health. 1997;3:31–51.
34. Witt DR, Schaefer C, Hallam P, et al. Cystic fibrosis heterozygote screening in 5,161
pregnant women. Am J Hum Genet. 1996;58:823–35.
35. Clayton EW, Hannig VL, Pfotenhauer JP, et al. Lack of interest by nonpregnant
couples in population-based cystic fibrosis carrier screening. Am J Hum Genet.
1996;58:617–27.

36. Loader S, Caldwell P, Kozyra A, et al. Cystic fibrosis carrier population screening in
the primary care setting. Am J Hum Genet. 1996;59:234–47.
37. Rimpela M, Contula O, Notkola I-L. Attitudes towards abortion in Finland. Ntl Res
Dev Ctr Welfare and Health. 1993;34
38. Gitsels-van der Wal JT, Mannien J, Ghaly MM, et al. The role of religion in
decision-making on antenatal screening of congenital anomalies: a qualitative study
amongst Muslim Turkish origin immigrants. Midwifery. 2014;30:297-302.
39. Fransen MP, Wildschut HI, Mackenbach JP, et al. Ethnic and socio-economic
differences in uptake of prenatal diagnosis tests for Down’s Syndrome. Eur J Obstet
Gynecol Reprod Biol. 2010;151:158-62.
40. Seror V, Ville Y. Prenatal screening for Down’s Syndrome: women’s involvement
in decision-making and their attitudes to screening. Prenat Diagn. 2009;29:120-8.
41. Morris BA, Hadley DW, Koehly LM. The Role of Religious and Existential Wellbeing in Families with Lynch Syndrome: Prevention, Family Communication, and
Psychosocial Adjustment. J Genet Counsel. 2013;22:482–91.
42. Modell SM, Citrin T, King SB, et al. The role of religious values in decisions about
genetics and the public’s health. J Relig Health. 2014;53:702–14.
43. Peters JA, Kenen R, Bremer R, et al. Easing the burden: Describing the role of social,
emotional and spiritual support in research families with Li-Fraumeni syndrome. J Genet
Counsel. 2016;25:529–42
44. Stuck J, Faine J, Boldt A. The perceptions of Lutheran pastors toward prenatal
genetic counseling and pastoral care. J Genet Couns. 2001;10(3):251-63.
45. McFarland MJ, Wright B, Weakliem D, et al. Educational attainment and
religiosity: Exploring variations by religious tradition. Soci of Rel. 2011;72(2):16688.
46. Chen LS, Goodson P. Factors affecting decisions to accept or decline cystic fibrosis
carrier testing/screening. Genet Med. 2007;9(7): 442-50.
47. Kraft SA, McMullen CK, Poster KM, et al. Patient perspectives on the use of
categories of conditions for decision making about genomic carrier screening results.
Am J Med Genet A. 2018;176(2):376-85.

48. Bonte P, Pennings G, Sterckx S. Is there a moral obligation to conceive children
under the best possible conditions?. BMC Med Ethics. 2014;15:5.
49. Gilmore MJ, Schneider J, Davis JV, et al. Reasons for declining preconception
expanded carrier screening using genome sequencing. J Genet Couns.
2017;26(5):971-9.
50. McEachan RRC, Conner M, Taylor RR, et al. Prospective prediction of healthrelated behaviors with the Theory of Planned Behavior: a meta-analysis. Health
Psychol Rev. 2011;5(2):97-144.
51. Godin G, Kok G. The theory of planned behavior: a review of its applications to
health-related behaviors. Am J Health Promot. 1996;11(2):87-98.
52. Fishbein MA, Ajzen I. Predicting and changing behavior: the reasoned action
approach. New York: Psychology Press. 2010.

